506919 Stock Overview
An integrated pharmaceutical company, manufactures and markets formulations in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Makers Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹173.80 |
| 52 Week High | ₹184.30 |
| 52 Week Low | ₹105.00 |
| Beta | 1.36 |
| 11 Month Change | 22.48% |
| 3 Month Change | 5.91% |
| 1 Year Change | 56.65% |
| 33 Year Change | -12.33% |
| 5 Year Change | 313.32% |
| Change since IPO | 382.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 506919 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 4.2% | 1.1% | 2.0% |
| 1Y | 56.6% | 43.3% | 28.6% |
Return vs Industry: 506919 exceeded the Indian Pharmaceuticals industry which returned 43.8% over the past year.
Return vs Market: 506919 exceeded the Indian Market which returned 29.5% over the past year.
Price Volatility
| 506919 volatility | |
|---|---|
| 506919 Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 506919 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 506919's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 121 | Saahil Parikh | www.makerslabs.com |
Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. The company offers general health therapeutic products, such as acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, digestives, neurotonics, nutritional supplements, topical anti-biotic/anti-microbial, and other specialties drugs.
Makers Laboratories Limited Fundamentals Summary
| 506919 fundamental statistics | |
|---|---|
| Market cap | ₹1.03b |
| Earnings (TTM) | ₹50.04m |
| Revenue (TTM) | ₹1.13b |
20.5x
P/E Ratio0.9x
P/S RatioIs 506919 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 506919 income statement (TTM) | |
|---|---|
| Revenue | ₹1.13b |
| Cost of Revenue | ₹596.52m |
| Gross Profit | ₹538.27m |
| Other Expenses | ₹488.23m |
| Earnings | ₹50.04m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.48 |
| Gross Margin | 47.43% |
| Net Profit Margin | 4.41% |
| Debt/Equity Ratio | 3.8% |
How did 506919 perform over the long term?
See historical performance and comparison